TrialClinical cancer research : an official journal of the American Association for Cancer Research2008

Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant.

Robert J Lechleider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.